Please note, this OEL/ADE monograph also applies to prednisolone (CAS RN 50-24-8), pethylprednisolone (CAS RN 83-43-2), prednisolone sodium phosphate (CAS RN 125-02-0), prednisolone 21-trimethylacetate (CAS RN 1107-99-9), prednisolone acetate (CAS RN 52-21-1), prednisolone hemisuccinate (CAS RN 2920-86-7), prednisolone sodium metazoate (CAS RN 630-67-1), prednisolone sodium succinate (CAS RN 1715-33-9), prednisolone steaglate (CAS RN 5060-55-9), prednisolone tebutate (CAS RN 681-14-3), prednisone acetate (CAS RN 125-10-0), and prednisolone farnesylate (CAS RN 118244-44-3). Prednisone is a synthetic glucocorticoid with anti-inflammatory and immunomodulating properties (2). Prednisone is indicated as an anti-inflammatory or immunosuppressive drug for allergic, dermatologic, gastrointestinal (GI), hematologic, ophthalmologic, nervous system, renal, respiratory, rheumatologic, infectious, endocrine, or neoplastic conditions as well as in organ transplant. Prednisone is therapeutically equivalent to its metabolite, prednisolone.
Affygility Solutions has an occupational exposure limit (OEL) and control band assignment for this active pharmaceutical ingredient (API). This monograph also contains the acceptable daily exposure (ADE) value.
OEL Fastrac monographs are a cost-effective and convenient way to meet the requirements for PDEs (ADEs) contained in the EMA Guideline on setting health based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities (EMA/CHMP/CVMP/SWP/169430/2012), as well as PIC/S and ANVISA requirements, and to obtain the following information:
To order an OEL/ADE monograph for Prednisone, just click the ADD TO CART button.
If you're wondering about HBEL, we have something for you.
Not the compound you were looking for? You can search the OEL Fastrac catalog to find more available compounds.
Affygility Solutions’ OEL Fastrac service is an user-friendly system that enables us to make confident decisions and focus on moving the compound safely through our facility. We can quickly access the database to determine if a new drug is within the OEL Fastrac library, and if so, immediately download a detailed OEL banding report. The OEL Fastrac system has been a helpful tool in our overall EH&S program.